Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
A number of methods are used for mutational analysis of BRCA1, a large multi-exon gene. A comparison was made of five methods to detect mutations generating premature stop codons that are predicted to result in synthesis of a truncated protein in BRCA1. These included four DNA-based methods: two-dimensional gene scanning (TDGS), denaturing high performance liquid chromatography (DHPLC), enzymatic mutation detection (EMD), and single strand conformation polymorphism analysis (SSCP) and an RNA/DNA-based protein truncation test (PTT) with and without complementary 5' sequencing. DNA and RNA samples isolated from 21 coded lymphoblastoid cell line samples were tested. These specimens had previously been analyzed by direct automated DNA sequencing, considered to be the optimum method for mutation detection. The set of 21 cell lines included 14 samples with 13 unique frameshift or nonsense mutations, three samples with two unique splice site mutations, and four samples without deleterious mutations. The present study focused on the detection of protein-truncating mutations, those that have been reported most often to be disease-causing alterations that segregate with cancer in families. PTT with complementary 5' sequencing correctly identified all 15 deleterious mutations. Not surprisingly, the DNA-based techniques did not detect a deletion of exon 22. EMD and DHPLC identified all of the mutations with the exception of the exon 22 deletion. Two mutations were initially missed by TDGS, but could be detected after slight changes in the test design, and five truncating mutations were missed by SSCP. It will continue to be important to use complementary methods for mutational analysis.
Andrulis
Irene L
IL
Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. andrulis@mshri.on.ca
Anton-Culver
Hoda
H
Beck
Jeanne
J
Bove
Betsy
B
Boyd
Jeff
J
Buys
Saundra
S
Godwin
Andrew K
AK
Hopper
John L
JL
Li
Frederick
F
Neuhausen
Susan L
SL
Ozcelik
Hilmi
H
Peel
David
D
Santella
Regina M
RM
Southey
Melissa C
MC
van Orsouw
Nathalie J
NJ
Venter
Deon J
DJ
Vijg
Jan
J
Whittemore
Alice S
AS
D019313:BRCA1 Protein / Q000235:genetics* / Q000378:metabolism; D024682:BRCA2 Protein / Q000235:genetics; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004247:DNA / Q000737:chemistry / Q000235:genetics*; D004252:DNA Mutational Analysis / Q000379:methods*; D015180:Electrophoresis, Gel, Two-Dimensional; D006801:Humans; D009154:Mutation; D018807:Polymorphism, Single-Stranded Conformational; D014176:Protein Biosynthesis; D012313:RNA / Q000235:genetics*; D012680:Sensitivity and Specificity; D014158:Transcription, Genetic
D019313:BRCA1 Protein; D024682:BRCA2 Protein; D012313:RNA; D004247:DNA